Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Thursday, July 28, 2011

Bayer-Trius - Has the World Gone Mad?

Bayer and Trius recently announced their collaboration on the development and commercialization of Trius’ antibiotic, torezolid, currently ...

Thursday, July 21, 2011

Novartis and Antibiotics - On the Edge

NOVARTIS HAS RETURNED THE RIGHTS TO AMADACYCLINE BACK TO PARATEK PHARMACEUTICALS!! This was correctly predicted by a Pharmawire article b...

Wednesday, July 20, 2011

Parachutes: Early vs. Late Endpoints

George Drusano, Paul Ambrose and Brad Spellberg - Special Guest Bloggers. “It’s not the fall that kills you, it’s the sudden stop.”--Ch...

Wednesday, July 13, 2011

Brief Update

Sanofi-Aventis -As predicted in a previous blog , it appears to be true that they are back in the antibiotics business for real. Sanofi ju...

Europe Strikes Again!

Image via Wikipedia The recent report of fully resistant strains of gonorrhea just adds fuel to the need for incentives to develop new an...

Friday, July 8, 2011

Current Regulations Distort the Competitive Environment for Clinical Trials

I have recently been thinking about the number of small companies trying to develop antibiotics. They are all pursuing indications like...

Superiority Trials in Antibiotic development

Image via Wikipedia In previous blogs, I promised that I would come back to the subject of superiority trials of antibiotics and the use of...

View web version

Powered by Blogger.